Cabozanix (Cabozantinib) 20 MG – 90 Capsules

Generic equivalent of Cabozantinibยฎ ยท Manufactured by Beacon Pharmaceuticals Limited

$810.00
Prices subject to change

Cabozanix (Cabozantinib) treats advanced medullary thyroid cancer by blocking specific proteins that promote cancer growth and spread. It targets multiple proteins including RET, MET, and VEGFR, among others, to slow or stop cancer progression.

whatsapp_qr
Whatsapp +8801922101029